Evaluation of the Best disease gene in patients with age-related macular degeneration and other maculopathies

Citation
R. Allikmets et al., Evaluation of the Best disease gene in patients with age-related macular degeneration and other maculopathies, HUM GENET, 104(6), 1999, pp. 449-453
Citations number
23
Categorie Soggetti
Molecular Biology & Genetics
Journal title
HUMAN GENETICS
ISSN journal
03406717 → ACNP
Volume
104
Issue
6
Year of publication
1999
Pages
449 - 453
Database
ISI
SICI code
0340-6717(199906)104:6<449:EOTBDG>2.0.ZU;2-0
Abstract
Vitelliform macular dystrophy (VMD2, Best disease, MIM153700) is an early o nset, autosomal, dominant macular degeneration characterized by the deposit ion of lipofuscin-like material within and below the retinal pigment epithe lium (RPE); it is associated with degeneration of the RPE and overlying pho toreceptors. Recently, we cloned the gene bestrophin, which is responsible for the disease, and identified a number of causative mutations in families with VMD2. Here, we report that the analysis of bestrophin in a collection of 259 age-related macular degeneration (AMD) patients provides evidence t hat mutations in the Best disease gene do not play a significant role in th e predisposition of individuals to AMD. However, our results suggest that, in addition to Best disease, mutations within the bestrophin gene could be responsible for other forms of maculopathy with phenotypic characteristics similar to Best disease and for other diseases not included in the VMD cate gory.